General Information
Revision date
2017-08-02
Product name
Performer
Substance name
mineral oil as emulsion
1.2.1 Relevant identified uses
Adjuvant
Icons in SDS
Company Information
company name
ARYSTA LifeScience South Africa (Pty) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
info@arysta.co.za
Section 2
SECTION 2: Hazards identification
Toxicity class WHO (a.i.) III; EPA (formulation) III Main Hazard: This compound inhibits cholinesterase enzyme activity in the nervous tissue and is toxic. Contact with skin, inhalation of spray, or swallowing may be fatal. Fire and explosion hazard: Product is flammable. Acute effects of overexposure: May cause temporary irritation to eyes, nose, throat and respiratory tract. If swallowed and aspirated into the lungs, chemical pneumonia can occur. Symptoms of exposure to the product include: headache, dizziness, anxiety, tremors of the tongue and eyelids, sweating, nausea, constricted pupils, vision impairment, abdominal cramps, diarrhoea, salivation, respiratory difficulty, cyanosis, convulsions, coma. May cause skin irritation, eye irritation and conjunctivitis. May be irritating to the respiratory tract and mucous membranes. Ingestion: Toxic by if swallowed. Inhalation: Harmful by inhalation. Skin contact: Toxic in contact with skin. Moderate irritant. May cause dermatitis through defatting of tissue. May cause skin sensitization. Eye contact: Moderate irritant to the eyes and may cause damage. SECTION 4 - FIRST AID MEASURES AND PRECAUTIONS Inhalation: If vapours or mists have been inhaled, and irritation has developed, remove the source of contamination or move victim to fresh air. The patient should be kept under observation and obtain medical attention if irritation persists.